problem with cryptocurrency Top Knowledge

SDIC Power and others have invested in the establishment of a new energy development company. The enterprise search APP shows that recently, Ganzi Yalongjiang Energy Development Co., Ltd. was established with Zhang Peng as its legal representative and a registered capital of 500 million yuan. Its business scope includes: solar power generation technical services; Research and development of emerging energy technologies; Technical services for wind power generation; Energy storage technology services, etc. Enterprise equity penetration shows that the company is jointly owned by Yalong River Basin Hydropower Development Co., Ltd. and Ganzi Energy Development Group Co., Ltd., a subsidiary of SDIC Power.With the intensive IPO process of domestic semiconductor companies, we can seize new opportunities in the semiconductor chip industry through the semiconductor ETF(512480). On December 11th, the semiconductor ETF(512480) closed up 0.20% with a turnover of 1.29 billion yuan. The constituent stocks are mixed. In terms of rising, the Cambrian led the rise, and Weir shares followed. In terms of decline, Zhongwei Company led the decline, and Haiguang Information followed suit. In the news, in the fourth quarter of 2024, the IPO acceptance review in science and technology innovation board has been accelerated, with 12 companies updating their review status, mostly in the semiconductor industry. According to industry insiders, from the current audit dynamics, materials, parts and components in the upstream of the industry, as well as AI chips in the design process, may be more popular in the future. Guojin Securities pointed out that semiconductor self-control is the general trend, and it is optimistic about semiconductor equipment parts, materials and domestic computing power industry chain. CITIC Securities said that it is expected that the overall localization pace of the domestic semiconductor industry will be further accelerated, and the manufacturing sector is also expected to benefit. Investors can take advantage of the semiconductor ETF(512480) to grasp the new opportunities in the semiconductor chip industry.As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.

Jizhi Co., Ltd.: Signed a supplementary agreement on development cooperation of 1.1 million yuan, and Jizhi Co., Ltd. announced that the company signed a supplementary agreement on entrusted development cooperation projects with Jiang Laboratory and Hangzhou Dilting Intelligent Technology Co., Ltd. According to the agreement, all parties have completed the development of intelligent underwater acoustic signal products, and will accelerate the application, promotion and industrialization of related products. The supplementary agreement stipulates that Jizhi shares will donate 1.1 million yuan to Zhejiang Zhijiang Development Foundation for public welfare. The signing of this agreement does not involve related party transactions, nor does it constitute a major asset restructuring. It still needs to be submitted to the company's second extraordinary shareholders meeting in 2024 for consideration. The signing of the agreement has limited impact on the company's short-term financial situation, but it is expected to have important strategic significance for the company's business development in the process of industrialization of related products.Hailiang shares: 325,700 shares of the company were repurchased for the first time. Hailiang shares announced that on December 10, 2024, the company repurchased 325,700 shares through a special account for stock repurchase, accounting for 0.0163% of the company's total share capital. The highest transaction price was 10.86 yuan/share, the lowest transaction price was 10.52 yuan/share, and the total transaction amount was 3,518,700 yuan. This repurchase conforms to the requirements of the company's repurchase plan and relevant laws and regulations.On the 11th, alumina fell by 3.61%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract alumina 2502 closed, with a volume of 174,600 lots. The position data showed that the top 20 seats were net, and the difference position was 10,936 lots. The total turnover of alumina futures contracts was 452,500 lots, an increase of 77,000 lots over the previous day. The first 20 seats in the contract held 264,800 lots, a decrease of 4,558 lots from the previous day. The short positions in the top 20 seats of the contract were 215,500 lots, a decrease of 1,290 lots from the previous day. (Sina Futures)

Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.The Taiwan Affairs Office of the State Council introduced the annual meeting of the 2024 Cross-Strait Entrepreneur Summit. Zhu Fenglian, a spokesperson for the Taiwan Affairs Office, said that the 2024 Cross-Strait Entrepreneur Summit was successfully held in Xiamen, Fujian from December 9 to 10. More than 700 business people from both sides of the Taiwan Strait attended the annual summit. Focusing on the theme of "Building a new era industrial chain across the Taiwan Strait to promote cross-strait economic integration and development", they conducted in-depth discussions on issues such as promoting cross-strait industrial Internet innovation, building Taiwanese enterprises to land in their first homes, and innovating cross-strait financial service systems. The exchange atmosphere was warm, which fully demonstrated the common aspiration of cross-strait industries to strengthen exchanges and cooperation. (Riyue Tan Tian)Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.